Johnson & Johnson (JNJ) Unit Recalls Bone Putty  
8/22/2012 7:13:49 AM

Synthes, a unit of Johnson & Johnson that has its U.S. headquarters in West Chester, Pa., has issued a recall for its hemostatic bone putty product, the Philadelphia Business Journal reports. A recall notice published on the Food and Drug Administration website notes the reason for the recall is the “potential for hemostatic bone putty to ignite if contacted with electrosurgical cautery systems under certain conditions during surgery.”

Johnson & Johnson (NYSE:JNJ) acquired Synthes, a medical-device maker that specializes in spine- and bone-repair products, for $21.3 billion in June.